• Rachel Blue, Andrew I Yang, Cecilia Zhou, Emma De Ravin, Clare W Teng, Gabriel R Arguelles, Vincent Huang, Connor Wathen, Stephen P Miranda, Paul Marcotte, Neil R Malhotra, William C Welch, and Lee John Y K JYK Department of Neurosurgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA..
• Department of Neurosurgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA. Electronic address: rachel.blue@uphs.upenn.edu.
• World Neurosurg. 2020 Jul 1; 139: 549-557.

AbstractDespite the substantial growth of telemedicine and the evidence of its advantages, the use of telemedicine in neurosurgery has been limited. Barriers have included medicolegal issues surrounding provider reimbursement, interstate licensure, and malpractice liability as well as technological challenges. Recently, the coronavirus disease 2019 (COVID-19) pandemic has limited typical evaluation of patients with neurologic issues and resulted in a surge in demand for virtual medical visits. Meanwhile, federal and state governments took action to facilitate the rapid implementation of telehealth programs, placing a temporary lift on medicolegal barriers that had previously limited its expansion. This created a unique opportunity for widespread telehealth use to meet the surge in demand for remote medical care. After initial hurdles and challenges, our experience with telemedicine in neurosurgery at Penn Medicine has been overall positive from both the provider and the patients' perspective. One of the unique challenges we face is guiding patients to appropriately set up devices in a way that enables an effective neuroexamination. However, we argue that an accurate and comprehensive neurologic examination can be conducted through a telemedicine platform, despite minor weaknesses inherent to absence of physical presence. In addition, certain neurosurgical visits such as postoperative checks, vascular pathology, and brain tumors inherently lend themselves to easier evaluation through telehealth visits. In the era of COVID-19 and beyond, telemedicine remains a promising and effective approach to continue neurologic patient care.Copyright © 2020 Elsevier Inc. All rights reserved.

27 keywords...

hide…